Erratum: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): Study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study (Trials (2020) 21 (80) DOI: 10.1186/s13063-019-3965-4)

Frank Tegtmeier; Reinhard Schinzel; Ronny Beer; Diederik Bulters; Jean Yves Lefrant; Joan Sahuquillo; Andreas Unterberg; Peter Andrews; Antonio Belli; Javier Ibanez; Alfonso Lagares; Michael Mokry; Harald Willschke; Charlotte Flüh; Erich Schmutzhard

ArticleOPEN ACCESS

Erratum: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): Study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study (Trials (2020) 21 (80) DOI: 10.1186/s13063-019-3965-4)

Trials

DOI: 10.1186/s13063-020-4107-8

1Citations

7Readers

Abstract

After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled. Original name spelling: Charlotte Flühe Correct name spelling: Charlotte Flüh The original article has been corrected.

Cite

CITATION STYLE

APA

Tegtmeier, F., Schinzel, R., Beer, R., Bulters, D., Lefrant, J. Y., Sahuquillo, J., … Schmutzhard, E. (2020, February 12). Erratum: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): Study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study (Trials (2020) 21 (80) DOI: 10.1186/s13063-019-3965-4). Trials. BioMed Central Ltd. https://doi.org/10.1186/s13063-020-4107-8

Erratum: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): Study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study (Trials (2020) 21 (80) DOI: 10.1186/s13063-019-3965-4)

Abstract

Cite

Register to see more suggestions